Sign Out
APO-DUTASTERIDE is used alone (monotherapy) in the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with enlarged prostates.
APO-DUTASTERIDE is also used in combination with the alpha blocker, tamsulosin, in the treatment of moderate to severe symptomatic BPH in men with enlarged prostates.
Combination therapy was also shown to be better than tamsulosin, but not APO-DUTASTERIDE at reducing the risk of acute urinary retention (or where patient suddenly cannot urinate at all) and/or the need for BPH related surgery.
APO-DUTASTERIDE is not approved for use in the prevention of prostate cancer.
